Mark G. Currie
69Patents
15h-index
82Co-inventors
87Inventor score
Filing activity: Sep 23, 1991 → Mar 13, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7205329B2 | Modulators of CRTH2 activity | Chemistry; Metallurgy | 98 | Expired |
| US5489670A | Human uroguanylin | Human Necessities | 52 | Expired |
| US5969097A | Human guanylin | Chemistry; Metallurgy | 51 | Expired |
| US5707984A | Steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs | Human Necessities | 38 | Expired |
| US7304036B2 | Methods and compositions for the treatment of gastrointestinal disorders | Chemistry; Metallurgy | 31 | Expired |
| US7494979B2 | Method for treating congestive heart failure and other disorders | Human Necessities | 27 | Expired |
| US7371727B2 | Methods and compositions for the treatment of gastrointestinal disorders | Human Necessities | 25 | Expired |
| US6046211A | Amidino derivatives useful as nitric oxide synthase inhibitors | Chemistry; Metallurgy | 23 | Expired |
| US5837698A | Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs | Chemistry; Metallurgy | 23 | Expired |
| US5140102A | Pentadecapeptide, guanylin, which stimulates intestinal guanylate cyclase | Human Necessities | 19 | Expired |
| US7772188B2 | Methods and compositions for the treatment of gastrointestinal disorders | Human Necessities | 18 | Active |
| US7910546B2 | Methods and compositions for the treatment of gastrointestinal disorders | Human Necessities | 17 | Active |
| US7745409B2 | Methods and compositions for the treatment of gastrointestinal disorders | Chemistry; Metallurgy | 16 | Active |
| US7704947B2 | Methods and compositions for the treatment of gastrointestinal disorders | Human Necessities | 16 | Active |
| US7087785B2 | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide | Chemistry; Metallurgy | 15 | Expired |
| US8088935B2 | Compounds and methods for the treatment of asthma | Chemistry; Metallurgy | 15 | Active |
| US8101579B2 | Methods and compositions for the treatment of gastrointestinal disorders | Human Necessities | 14 | Active |
| US9481689B2 | sGC stimulators | Emerging Cross-Sectional Technologies | 13 | Active |
| US8080526B2 | Methods and compositions for the treatment of gastrointestinal disorders | Human Necessities | 13 | Active |
| US8110553B2 | Methods and compositions for the treatment of gastrointestinal disorders | Chemistry; Metallurgy | 13 | Active |
| US7105699B2 | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide | Chemistry; Metallurgy | 13 | Expired |
| US7253156B2 | Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists | Human Necessities | 11 | Expired |
| US7790772B2 | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine | Chemistry; Metallurgy | 11 | Active |
| US5854234A | Amidino dervatives useful as nitric oxide synthase inhibitors | Chemistry; Metallurgy | 11 | Expired |
| US7589237B2 | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine | Chemistry; Metallurgy | 11 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.